Guson Kang, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kang’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A127411 · Current
Licensed to practise in California · since 2013 · expires 2027-05-31 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$40,782
Medicare paid this office $40,782 for 109 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 66 | $11,502 | $172 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,115 | $482 |
| Biopsy of heart muscle | 11 | $2,120 | $177 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,260 | $79 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 89 | $986 | $10 |
See all 6 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 66 | $11,502 | $172 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $10,115 | $482 |
| Biopsy of heart muscle | 11 | $2,120 | $177 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,260 | $79 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 89 | $986 | $10 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $662 | $60 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 17 | More than 43% of doctors who do this |
Who their Medicare patients are
109 Original Medicare patients in 2024. Average age 72 · Women 38% · Also on Medicaid 34% · Health risk score 2.29. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Heart failure 68% · Chronic kidney disease 59% · Atrial fibrillation 53% · Diabetes 46% · COPD 23% · Depression 22% · Stroke 22% · Cancer 16% · Dementia 11%.
The office billed $691,099, Medicare allowed $51,390 and paid $40,782; for 285 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 109 | 285 | 72 | 2.29 | $691,099 | $40,782 |
| 2023 | 113 | 256 | 71 | 2.24 | $564,285 | $38,005 |
| 2022 | 72 | 153 | 72 | 2.62 | $255,204 | $20,156 |
| 2021 | 41 | 91 | 70 | 2.56 | $165,716 | $13,410 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 62 | $10,602 | $171 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 17 | $8,775 | $462 |
| Biopsy of heart muscle | 19 | $3,962 | $180 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 72 | $343 | $5 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $193 | $11 |
2022: 3 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 35 | $6,772 | $193 |
| Biopsy of heart muscle | 15 | $3,617 | $201 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 53 | $255 | $5 |
2021: 2 services
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 22 | $4,200 | $191 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $216 | $11 |
Medicaid work
$222 in 2024
Medicaid paid $222 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 13 | $222 |
| 2024 | 13 | 1 | 12 | $222 |
Money from drug and device companies
$2,332 in 2025
| 2025 | 5 | 15 | None | $2,332 |
| 2024 | 7 | 16 | $1,225 | $2,651 |
| 2023 | 3 | 4 | None | $168 |
| 2022 | 5 | 27 | $500 | $2,760 |
| 2021 | 3 | 3 | None | $52 |
| 2020 | 4 | 8 | $1,913 | $2,450 |
| 2019 | 4 | 14 | None | $19,111 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Evoque | $1,999 | 9 payments
|
| Inspire Medical Systems | Inspire | $178 | 1 payment
|
| Abbott Laboratories | Amplatzer | $103 | 3 payments
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $32 | 1 payment
|
| Boston Scientific | Watchman Flx | $20 | 1 payment
|
See all 15 published payments
| W. L. Gore & Associates | Meals · 2025-12-09 | Gore Cardioform Septal Occluder | $32 |
| Edwards Lifesciences | Travel · 2025-11-07 | Evoque | $260 |
| Edwards Lifesciences | Meals · 2025-11-04 | Evoque | $29 |
| Boston Scientific | Meals · 2025-10-31 | Watchman Flx | $20 |
| Edwards Lifesciences | Meals · 2025-10-03 | Evoque | $48 |
| Edwards Lifesciences | Travel · 2025-09-25 | Evoque | $932 |
| Edwards Lifesciences | Meals · 2025-09-24 | Evoque | $7 |
| Edwards Lifesciences | Meals · 2025-09-22 | Evoque | $43 |
| Edwards Lifesciences | Meals · 2025-09-22 | Evoque | $31 |
| Edwards Lifesciences | Travel · 2025-09-08 | Evoque | $621 |
| Abbott Laboratories | Meals · 2025-09-05 | Amplatzer | $46 |
| Abbott Laboratories | Meals · 2025-09-05 | Amplatzer | $34 |
| Inspire Medical Systems | Meals · 2025-08-06 | Inspire | $178 |
| Edwards Lifesciences | Meals · 2025-07-08 | Evoque | $26 |
| Abbott Laboratories | Meals · 2025-03-27 | Mitraclip | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,651
| Abbott Laboratories | None | $1,255 | 8 payments
|
| CathWorks | Ffrangio | $625 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $600 | 1 payment
|
| Abiomed | Impella | $104 | 3 payments
|
| Cardiva Medical | Savvywire | $43 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $18 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $6 | 1 payment
|
2023: $168
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $104 | 1 payment
|
| Abbott Laboratories | Mitraclip | $49 | 2 payments
|
| Terumo Medical | Glidewire | $15 | 1 payment
|
2022: $2,760
| Abbott Laboratories | Mitraclip | $2,108 | 20 payments
|
| E.R. Squibb & Sons L.L.C. | None | $500 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $76 | 3 payments
|
| Boston Scientific | Watchman Access System | $61 | 2 payments
|
| Medtronic | Corevalve Evolut R | $14 | 1 payment
|
2021: $52
| Abbott Laboratories | Dragonfly Oct | $24 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $15 | 1 payment
|
| Penumbra | Indigo System | $12 | 1 payment
|
2020: $2,450
| Abbott Laboratories | Xience V Coronary Stent System | $2,190 | 3 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $176 | 3 payments
|
| Medtronic Vascular | Corevalve Evolut | $43 | 1 payment
|
| Boston Scientific | General - Structural Heart | $41 | 1 payment
|
2019: $19,111
| Medtronic Vascular | Corevalve Evolut | $18,000 | 1 payment
|
| Abbott Laboratories | Mitra Clip System | $474 | 3 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $350 | 6 payments
|
| Boston Scientific | General Structural Heart | $287 | 4 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1033485057
- Licence
- CA A127411, MI 4301116890California A127411: Current · expires 2027-05-31
- Trained
- Yale University School of Medicine, 2012
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-03-23
- NPI last updated
- 2024-04-22
- NPI record certified
- 2024-04-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6777 W Maple Rd, West Bloomfield, MI, 48322